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Abstract
Pentachlorophenol (PCP) induced expression of the NalC repressor-regulated PA3720-armR operon and the MexR repressor-
controlled mexAB-oprM multidrug efflux operon of Pseudomonas aeruginosa. PCP’s induction of PA3720-armR resulted from
its direct modulation of NalC, the repressor’s binding to PA3720-armR promoter-containing DNA as seen in electromobility
shift assays (EMSAs) being obviated in the presence of this agent. The NalC binding site was localized to an inverted repeat
(IR) sequence upstream of PA3720-armR and overlapping a promoter region whose transcription start site was mapped.
While modulation of MexR by the ArmR anti-repressor explains the upregulation of mexAB-oprM in nalC mutants
hyperexpressing PA3720-armR, the induction of mexAB-oprM expression by PCP is not wholly explainable by PCP induction
of PA3720-armR and subsequent ArmR modulation of MexR, inasmuch as armR deletion mutants still showed PCP-inducible
mexAB-oprM expression. PCP failed, however, to induce mexAB-oprM in a mexR deletion strain, indicating that MexR was
required for this, although PCP did not modulate MexR binding to mexAB-oprM promoter-containing DNA in vitro. One
possibility is that MexR responds to PCP-generated in vivo effector molecules in controlling mexAB-oprM expression in
response to PCP. PCP is an unlikely effector and substrate for NalC and MexAB-OprM - its impact on NalC binding to the
PA3720-armR promoter DNA occurred only at high mM levels - suggesting that it mimics an intended phenolic effector/
substrate(s). In this regard, plants are an abundant source of phenolic antimicrobial compounds and, so, MexAB-OprM may
function to protect P. aeruginosa from plant antimicrobials that it encounters in nature.
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Introduction
Pseudomonas aeruginosa is an opportunistic pathogen associated
with debilitating infections of immunocompromised individuals
and individuals with cystic fibrosis [1] and is characterized by an
innate resistance to many antimicrobials and the ability to
develop/acquire resistance [2]. Significant contributors to this
intrinsic and/or acquired multidrug resistance are several
members of the RND family of multidrug efflux systems [2–4],
particularly that encoded by the mexAB-oprM efflux operon.
MexAB-OprM exhibits one of the broadest substrate profiles of
the RND pumps in P. aeruginosa, accommodating a wide range of
clinically-relevant antimicrobials [5] and biocides [6] as well as a
variety of non-clinical agents (e.g., organic solvents [7,8], dyes [9–
11], detergents [10], metabolic inhibitors [12], acylhomoserine
lactones (AHLs) associated with quorum-sensing (QS) [13,14]). An
important determinant of intrinsic multidrug resistance [9] this
efflux system contributes to acquired fluoroquinolone [15–17] and
b-lactam [18–23] resistance in clinical isolates of P. aeruginosa.
Expression of the mexAB-oprM operon is regulated by the
product of a local repressor gene, mexR [24], occurring upstream of
the efflux genes and the target of mutation in MexAB-OprM-
overexpressing multidrug-resistant nalB lab [24,25] and clinical
[26–28] isolates. MexR acts to control mexAB-oprM expression
from one of two promoters (PI; most distal from the efflux genes)
for this efflux operon [29,30], binding as a dimer [31] to a site that
also overlaps the mexR promoter [29,32] and, so, effects negative
autoregulation. Recent studies show that its ability to bind and so
repress mexAB-oprM is governed by the redox status of the protein,
MexR serving to regulate mexAB-oprM expression in responsive to
oxidative stress [33,34]. MexR repressor activity is also modulated
by the product of the armR anti-MexR repressor gene, which binds
to MexR and negatively impacts its ability to bind to the mexAB-
oprM PI promoter region [35,36]. armR occurs as part of the 2-gene
operon PA3720-armR that is regulated by the product of the
divergently-transcribed nalC repressor gene [37], with nalC
mutants showing elevated PA3720-armR expression and, so,
elevated mexAB-oprM expression and multidrug resistance [37] as
a result of ArmR modulation of MexR’s repressor activity [35].
nalC lab and clinical isolates expressing mexAB-oprM and showing a
multidrug-resistant phenotype have been reported [24,37,38]. A
third repressor involved in regulating mexAB-oprM expression,
NalD, is encoded by a gene unlinked to mexAB-oprM and nalC/
PA3720-armR and regulates mexAB-oprM from a second, efflux
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described in lab and clinical multidrug-resistant mutants [39].
Despite their contribution to antimicrobial resistance, RND family
multidrug efflux systems in P. aeruginosa are increasingly appreciated
as having other than drug efflux as an intended function, most of
these systems being regulated independently of antimicrobials and
instead induced in response to environmental stress (e.g, MexCD-
OprJ, envelope stress [40]; MexEF-OprN, nitrosative stress [41];
MexXY-OprM, oxidative [42] and ribosome [43,44] stress).
Recently, the mexAB-oprM efflux system and its regulatory locus
nalC/PA3720-armR have been shown to be inducible by the
uncoupler of oxidative phosphorylation and environmental contam-
inant, pentachlorophenol (PCP) [45], the implication being that this
compound is being ‘sensed’ by NalC and mexAB-oprM recruited as a
result of ArmR-mediated MexR modulation. While MexAB-OprM
appears able to accommodate this toxin (mutants lacking the pump
are more sensitive to PCP) [45], it is unclear whether PCP is the
actual signal/substrate or whether downstream effects of the
uncoupling of oxidative phosphorylation are responsible for nalC/
PA3720-armR and mexR/mexAB-oprM upregulation. The current
study was undertaken to address this and to ascertain the mechanism
by which PCP ultimately induces mexAB-oprM. We report here that
NalC is a PCP-responsive repressor that mediates PCP induction of
PA3720-armR and, possibly, mexAB-oprM but that PCP is also able to
induce mexAB-oprM expression independently of PA3720-armR,
possibly as a result of PCP-generated oxidative stress and, so, redox
regulation of MexR. During the course of this work another study
demonstrating PCP control of NalC repressor activity was published
[46] although the mechanism(s) by which this toxin induced mexAB-
oprM were not assessed, and the assumption that it was via ArmR are
not supported by our study.
Materials and Methods
Bacterial strains and plasmids
The bacterial strains and plasmids used in this study are listed in
Table 1. Bacterial cells were cultured in Luria broth (L broth) and
on Luria agar with antibiotics, as necessary, at 37uC. Plasmid
pET23a and its derivatives were maintained in E. coli with
ampicillin (100 mg/ml). Plasmid pEX18Tc and its derivatives were
maintained in E. coli with tetracycline (10 mg/ml). Plasmid pLysS
was maintained in E. coli with chloramphenicol (30 mg/ml).
DPA3720 derivatives of P. aeruginosa strains K767 and K3145
(DarmR) were generated by constructing a PA3720 deletion in
plasmid pEX18Tc and mobilizing it into these strains as before
[47]. Briefly, 1 kb fragments corresponding to sequences 59 and 39
to the PA3720 sequences being deleted were amplified using the
polymerase chain reaction (PCR) and primers 3720 UF (59-
GCTAGAATTCGTAGGTGGTGAAGCCGAGC-39; EcoRI site
underlined) and 3720 UR (59-GCTAGGTACCTGACGCCGC-
CATGTCCCT-39; KpnI site underlined), and 3720 DF (59-
GCTAGGTACCCATGGGGGGACTCCTGCG-39; KpnI site
underlined) and 3720 DR (59-GCTAAAGCTTCCTG-
GTCCTGGCGACACG-39; HindIII site underlined), respectively.
The 50 ml PCR reaction mixture contained 1 mg of chromosomal
P. aeruginosa K767 DNA as template, 1 mM of each primer,
0.3 mM each deoxynucleoside triphosphate (dNTP), 16 Exact
buffer, 16 5P buffer and 2.5 U Exact DNA polymerase (5
PRIME, Inter Medico, Markham, Ontario). Following an initial
denaturation step at 95uC for 5 min, the mixture was subjected to
30 cycles of heating at 94uC for 45 sec, 63uC (annealing
temperature) for 30 sec, and 72uC for 1 min, before finishing
with a10-min incubation at 72uC. PCR products were gel purified,
digested appropriately and cloned sequentially into pEX18Tc, to
yield the DPA3720 vector, pLMS2. Plasmid pLMS2 was mobilized
into P. aeruginosa K767 from into E. coli S17-1 and P. aeruginosa
transconjugants harbouring chromosomal inserts of the deletion
vector were selected on L-agar plates containing tetracycline
(50 mg/ml) and chloramphenicol (5 mg/ml; to counterselect E. coli
S17-1). These were subsequently streaked onto L agar containing
sucrose (10% [wt/vol]) as before [48], with sucrose-resistant
colonies screened for the appropriate deletion using colony PCR
[49] with primers 3720 UF and 3720 DR and parameters detailed
above (except for an annealing temperature of 55uC). A DarmR
derivative of P. aeruginosa K767 was constructed using pEX18Tc::
DarmR plasmid pLC8 as described previously [37] except that
transconjugants carrying chromosomal inserts of the deletion
vector were selected on L-agar plates containing tetracycline and
chloramphenicol as above. DarmR mutants were verified by colony
PCR [49] using primers 3719UF (59-CGGTGAGCGTGG-
CGCCG-39) and 3720DR (59-TGGGCTCTTTACCTCAAGT-
39). Reaction mixtures were heated to 95uC for 5 min followed by
30 cycles of 30 sec at 94uC, 30 sec at 60uC, 1 min at 72uCa n da
final 5-min elongation at 72uC.
DNA methods
Standard protocols were used for restriction endonuclease
digestion, ligation, transformation, plasmid isolation, agarose gel
electrophoresis, and preparation of chemically competent (CaCl2) E.
coli cells as described by Sambrook and Russell [50]. Electrocompetent
P. aeruginosa cells were prepared as described by Choi and Shwiezer
[51]. Chromosomal DNA was extracted from P. aeruginosa using the
DNeasy Tissue Kit (Qiagen, Inc., Mississauga, Ontario). Plasmid
DNAs were also prepared from E. coli or P. aeruginosa using a GeneJET
Plasmid Miniprep kit (Fermentas Canada Inc., Burlington, Ontario,
Canada) according to a protocol provided by the manufacturer. The
WizardH SV Gel and PCR Clean-Up System kit (Promega Corp.,
Nepean, Ontario) was used to purify PCR products and to gel-purify
DNA fragments generated by restriction endonuclease digestion.
Oligonucleotides were synthesized by Integrated DNA Technologies
(IDT, Coralville, Iowa, USA) and nucleotide sequencing was
performed by AGCT Corp. (Toronto, Ontario).
Susceptibility testing
The antimicrobial susceptibilities of the various P. aeruginosa
strains were assessed in 96-well microtiter plates using twofold
serial dilutions as described [52]. In assessing the impact of PCP
exposure on antimicrobial susceptibility, 0.75 mM PCP (one
quarter of the MIC) was included in the growth medium used to
prepare the bacterial inoculum and to generate the serial dilutions.
Quantitative RT-PCR
Overnight cultures of P. aeruginosa strains were subcultured
(1:49) in fresh L-broth and incubated at 37uC with shaking for
2.5 hours, at which time cells were harvested by centrifugation. In
some experiments, PCP (0.75 mM final concentration; J MIC)
was added 1 to 1.5 hr before harvesting. Total bacterial RNA was
isolated from 1 ml of late-log phase culture using the RiboPure
TM
Bacteria kit (Ambion, Inc., Streetsville, Ontario) or the High Pure
RNA Isolation Kit (Roche Diagnostics) using the manufacturers’
protocols, and resuspended in 50 ml elution buffer. Samples were
treated with Turbo DNA-Free (Ambion, Inc; 2 U enzyme per
10 mg of RNA for 60 min at 37u). DNA-free RNA (confirmed usng
PCR; 1 mg) was used to synthesize cDNA using an iScript cDNA
Synthesis kit (Bio-Rad, Mississauga, Ontario) in a reaction mixture
formulated as described by the kit manufacturer and incubated for
5 min at 25uC, 30 min at 42uC and 5 min at 85uC. cDNA was
then stored until needed at 220uC. Quantification of the cDNA
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TM Real-Time PCR
Detection System (Bio-Rad, Mississauga, Ontario). PCR amplifi-
cation reactions were performed in 20 ml reaction volumes each
containing 10 ml of SsoFast EvaGreen Supermix (Bio-Rad,
Mississauga, Ontario), 0.6 mM each of 2 primers per gene being
amplified (mexA: mexAQ-F, 59-CAGCAGCTCTACCAGATCG-
39 and mexAQ-R, 59-CGTACTGCTGCTTGCTCA-39;P A
3720: 3720Q-F, 59-GATGCCTTTCCCTTGGTC-CA-39 and
3720Q-R, 59-TCCTTGAGCCACAACACCAG-39; rpsL: rpsLQ-
F, 59-GGT-TTCCTCGTACATCGGTG-39 and rpslQ-R, 59-
TGCTTACGGTCTTTGACACC-39) and 5 ml of 1:49 diluted
cDNA. Following an initial 3-min denaturation at 95uC, the
mixture was subjected to 40 cycles of 10 sec at 95uC and 30 sec at
60uC. A melt curve, obtained following an initial 10-sec treatment
at 95uC and involving 5-sec incubations of 0.5uC increments
beginning at 65uC, was run at the end of 40 cycles to test for the
presence of a unique PCR product. The expression levels of mexA
and PA3720 were normalized to that of the reference gene rpsL.
Biological duplicates and technical triplicates were performed for
all samples. To confirm the absence of genomic DNA contam-
ination, ‘no-template’ controls were performed in technical
triplicates for all primer sets employed.
Expression and purification of polyhistidine (His)-tagged
NalC protein
The nalC gene was amplified by PCR using primers: nalC-Fwd-
NdeI (59-GATCCATATGAACGATGCTTCTCCCCGTCTG-
3; NdeI site underlined) and nalC-Rev-SalI (59-GATCGTC-
GACGCCCTGCGCGGGGCTCTG-39; SalI site underlined) in
a5 0ml PCR reaction that contained 1 mg P. aeruginosa strain K767
chromosomal DNA, 0.2 mM each dNTP, 3% (vol/vol) DMSO,
16 PhusionH High Fidelity (HF) buffer and 1 U PhusionH
polymerase (Finnzymes, New England Biolabs, Pickering, On-
tario). The reaction mixture was heated for 30 sec at 94uC
followed by 30 cycles of 30 sec at 94uC, 30 sec at 54uC and 30 sec
at 72uC, before finishing with 10 min at 72uC. The nalC-
containing PCR product was purified, digested with SalI and
NdeI and cloned into NdeI-XhoI-restricted pET23a (Novagen,
Madison, Wisconsin, USA) to yield pLMS3 encoding His-tagged
NalC (i.e, NalC-His). Following nucleotide sequencing of the
cloned gene to confirm the absence of PCR-generated mutations,
plasmid pLMS3 was introduced into E. coli BL21 (DE3) carrying
the pLysS plasmid and NalC-His production induced with IPTG
using a modified version of a previously-described protocol [29].
Briefly, an overnight culture of E. coli BL21 (DE3) carrying pLysS
and pLMS3 was diluted 1:49 in LB (50 ml) supplemented with the
appropriate antibiotics and incubated at 37uC until the optical
density at 600 nm reached 0.5–0.6, at which time IPTG (1 mM
final concentration) was added and incubation continued a further
2 hr. Cells were harvested by centrifugation (10 min at 100006g)
at 4uC and pellets were resuspended in 6 ml buffer A (0.3 M
NaCl, 50 mM Na2HPO4) containing 5 mM imidazole and
sonicated (three sonic bursts of 30 sec, power 40 with a VibraCell
Sonicator [Sonics & Material Inc., Danbury, Connecticut, USA]).
Table 1. Bacterial strains and plasmids.
Strain Relevant characteristic Reference or source
E. coli
DH5aw 80D lacZDM15 endA1 recA1 hsdR17 (rK
2 mK
+) supE44 thi-1 gyrA96 relA1 F
2 D(lacZYA-argF)U169 [59]
K113 BL21 (DE3) (pLysS) [60]
K114 BL21 (DE3) (pLysE) [60]
S17-1 thi pro hsdR recA Tra+ [61]
Sm10(lpir) thi-1 thr lec tonA lacY supE recA::RP4-2-Tc::Mu;K m
r lpir [62]
NovaBlue recA
2 endA
2 lacI
q Novagen
P. aeruginosa
K767 PAO1 prototroph [63]
K1454 Spontaneous nalC mutant of K767 [24]
K2276 K1454 DarmR [37]
K2568 K767 DmexR [30]
K3145 K767 DarmR This study
K3146 K767 DPA3720 This study
K3130 K767 DPA3720-DarmR This study
K3151 K1454 DPA3720 This study
Plasmids
pET23a His-tag expression vector: Ap
r Novagen
pKLE1 pET23a::mexR [29]
pLMS3 pET23a::nalC This study
pEX18Tc Broad-host-range gene replacement vector; sacB;T c
r [64]
pLC8 pEX18Tc::DarmR [37]
pLMS2 pEX18Tc::DPA3720 This study
pMF1 pEX18Tc::DPA3720-DarmR This study
Ap
r, ampicillin resistant; Km
r, kanamycin resistant; Tc
r, tetracycline resistant.
doi:10.1371/journal.pone.0032684.t001
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containing supernatant was mixed with 500 ml of Ni-NTA Agarose
resin (Qiagen, Inc.) equilibrated with 10 ml buffer A containing
5 mM imidazole and incubated, with shaking, for 10 min. The
resin was subsequently pelleted by centrifugation (3 min at
30006g) and washed twice with 10 ml buffer A containing
5 mM imidazole and once with 2 ml buffer A containing 5 mM
imidazole, the resin again being centrifuged after each wash.
Bound protein was eluted stepwise with 500 ml buffer A containing
increasing amounts of imidazole (50, 100, 150, 250 mM); at each
step the resin was incubated with shaking at room temperature
and centrifuged as above. The NalC-His protein was recovered in
the supernatant following elution with buffer A containing
250 mM imidazole. Protein concentration was determined using
the BCA Protein Assay Kit (Pierce, Illinois, USA), and purified
protein (verified using SDS-polyacrylamide gel electrophoresis
[10]) was stored at 220uC in 20% (vol/vol) glycerol.
Electromobility shift assay
The binding of purified NalC (see above) and MexR (prepared as
above but using pET23a::mexR vector pKLE1 in place of pLMS3)
to PCR-amplified target DNAs was assessed using the electro-
mobility shift assay (EMSA) as described previously [30]. Briefly,
50 ng target DNA was incubated with purified NalC or MexR for
20 min at room temperature in a 15 ml reaction mixture containing
16binding buffer (750 mM KCl, 0.5 mM dithiothreitol, 0.5 mM
EDTA, 50 mM Tris-HCl, pH 7.4). Following the addition of
EMSA gel-loading solution, mixtures were separated by electro-
phoresis on a non-denaturing 8% (wt/vol) polyacrylamide gel in 0.5
TBE buffer (22 mM Tris-HCl, 22 mM boric acid, 0.5 mM EDTA,
pH 8.0) and gels were stained with 16SYBR Green EMSA nucleic
acid stain. DNA was then visualized using digital photography with
a S6656 SYPRO photographic filter (S6656).
NalC target DNAs included the entire nalC-PA3720 intergenic
region (205 bp), ca. 100 bp fragments corresponding to the
PA3720-distal and -proximal halves of this region as well as
shorter oligonucleotides corresponding to the putative NalC
binding site. Amplification of the 205 bp fragment was achieved
using primers nalC-3720 Fwd 1 (59-TGGGGGGACTC-
CTGCGGG-39) and nalC-3720 Rev 2 (59-GAGCGGTAT-
CGGGCCTCG-39) in a reaction mixture (50 ml) containing
1 mg chromosomal P. aeruginosa K767 DNA, 0.2 mM of each
dNTP, 30 pmol of each primer, 16ThermoPol buffer, 10% (vol/
vol) DMSO and 2 U Taq DNA polymerase (New England
Biolabs). The mixture was heated at 94uC for 30 sec, followed by
30 cycles of 30 sec at 94uC, 30 sec at 63uC, and 30 sec at 72uC,
before finishing with 10 min at 72uC. The 102-bp PA3720-
proximal fragment was amplified using primers nalC-3720 Rev 2
and nalC-3720 9 Fwd (59-CTAACGAGAAACGCTC-39)i na
mixture formulated as above and heated at 94uC for 45 sec,
followed by 30 cycles of 45 sec at 94uC, 45 sec at 50uC, and 45 sec
at 72uC for 45 sec, again finishing with 10 min at 72uC. The 107-
bp PA3720-distal fragment was amplified using primers nalC-3720
Fwd 1 and nalC-3720 8 Rev (59-TTAGGGTTGACG-
CTGGTCA-39) in a reaction mixture containing 1 mgo f
chromosomal DNA, 0.3 mM each dNTP, 1 mM of each primer,
16 Exact buffer and 2.5 U Exact DNA polymerase (5 PRIME,
Inter Medico, Markham, Ontario). The mixture was heated at
95uC for 5 min followed by 30 cycles of 30 sec at 94uC, 30 sec at
65uC, and 1 min at 72uC, before finishing with 7 min at 72uC.
Oligonucleotides (41 bp) corresponding to various regions up-
stream of PA3720-armR (NalC-1, 59-TGGTCATTT-AAGAAC-
TGTATCGTACAGTACTGTTTTGGCAA-39; NalC-2, TTG-
GCAAGCACT-TCCGCTCATTCCTCCGCCTTGCCTCCC-
GC-39; NalC-3, TGGTCATTTATCTTGA-CAATCGTACAG-
TACTGTTTTGGCAA-39), including a putative NalC-binding
site, and their reverse complements were annealed and also used in
EMSAs. Briefly, 75 pmol of each oligonucleotide pair was
annealed in 50 mld H 20 by heating for 3 min at 95uC, followed
by 10 min at 90uC, and 5 min at 10uC decrements to 30uCa t
which time the annealed oligonucleotides were cooled and stored
at 4uC.
The MexR target DNA, corresponding to the 351-bp mexR-
mexA intergenic region, was amplified using the primers K9 (59-
CTGAAGATCTGTTGCATAGCGTTG-TCCTCA-39)and K10
(59-ACGGGGTACCCGGGGTAGTTCATTGGTTTG-39)i na
reaction mixture formulated as above for the 205-bp nalC-PA3720
intergenic region, except that DMSO was excluded and MgCl2 was
included at 1.5 mM final concentration. The reaction was heated at
94uC for 5 min, followed by 30 cycles of 1 min at 94uC, 2 min at
56uC, and 1.5 min at 72uC, before finishing with 30 min at 72uC.
To assess the specificity of any binding observed, excess salmon
sperm DNA (100 mM) was added to the reaction mixtures prior to
theadditionofprotein.Inexperimentswherevariouscompoundsor
plant extracts were being tested for an ability to interfere with
protein-DNA binding, these were also added (concentrations
indicated in the appropriate figure legends) prior to adding the
protein. Since preparation of PCP required the use of a solvent
(10 mM NaOH), control experiments involving 10 mM NaOH
only were carried out to ensure that the solvent itself was not
impacting the EMSA.
Mapping the PA3720-armR transcription start site
To identify the transcription start site for the PA3720-armR
operon, the 59 rapid amplification of cDNA ends (RACE) protocol
[53] and a 59/39 RACE Kit, 2nd Generation (Roche Diagnostics)
were used as described previously with modifications [29]. Total
RNA was prepared from PA3720-armR-expressing P. aeruginosa
nalC mutant K1454 using the Roche High Pure RNA Isolation Kit
according to the manufacturer’s instructions, and contaminating
DNA was removed using the Turbo DNase Kit (Ambion). cDNA
was synthesized from total RNA (1 mg) with a RACE kit-provided
reverse transcriptase and a PA3720-specific primer, 3720 RACE
Sp1 (59-GGCGGATAGACCAGGG CGAAAT-39; anneals
131 bp downstream of the PA3720 ATG start site), using a
protocol provided by the manufacturer. A homopolymeric A-tail
was added to the 39 end of the total cDNA using terminal
transferase and dATP, and the dA-tailed cDNA subsequently PCR
amplified using a kit-provided oligo (dT)-anchor primer and a
second PA3720-specific primer, 3720 RACE Sp2 (59-
CGGCCAGCTCGCGGGGCATCT-39; anneals 57 bp down-
stream of the PA3720 ATG start site). The resulting PCR product
was purified and cloned into the pETBlue-1 AccepTor
TM Vector
(EMD Chemicals, Gibbstown, New Jersey, USA) as per
instructions provided by the manufacturer. Following transforma-
tion of NovaBlue Giga Singles Competent Cells (Novagen),
plasmid-carrying E. coli cells were selected on L-agar kanamycin
(50 mg/ml) and tetracycline (15 mg/ml). Plasmids carrying inserts
of the amplified 59 end of PA3720 mRNA were identified and the
inserts sequenced and aligned with the PAO1 genome sequence to
determine the PA3720-armR transcription start site.
Results
NalC mediates PCP inducibility of PA3720-armR
Microarray data has shown that PCP induces expression of the
NalC-regulated PA3720-armR operon [45], results that have been
confirmed here using quantitative RT-PCR (qRT-PCR) (Fig. 1).
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– although the mutant showed the expected increase in PA3720-
armR expression compared with its wild type parent K767, PCP
treatment did not enhance expression of this operon in K1454
(Fig. 1). This indicated that NalC was mediating the PCP
induction of PA3720-armR, either via a direct response to PCP
or via recognition of PCP-generated cellular products (PCP is an
energy inhibitor). To assess this NalC was purified and the impact
of PCP on its binding to the ca. 200 bp nalC-PA3720 intergenic
region was examined using EMSA. As seen in Fig. 2, NalC bound
the nalC-PA3720 intergenic region (Fig. 2A) with binding
compromised by the addition of PCP (some loss of binding was
detected at 10 mM PCP with almost complete loss of binding seen
at 750 mM) (Fig. 2B). Thus, NalC responds directly to PCP in
mediating its induction of PA3720-armR.
Mapping the NalC binding site
In an attempt to localize the NalC binding site NalC binding to
ca. 100 bp PA3720-proximal and ca. 100 bp PA3720 distal
fragments was assessed, with binding confirmed only for the
PA3720-proximal fragment (Fig. 3A, cf Fig. 3B). This fragment
(with endpoints II) included putative promoters for nalC and
PA3720-armR as well as an inverted repeat sequence that might
serve as the NalC-binding site (Fig. 4). To assess the latter, a 45 bp
fragment encompassing the inverted repeat (IR; endpoints III in
Fig. 4) was used in an EMSA and NalC binding was observed
(Fig. 3C). An identically-sized fragment lacking the IR and
encompassing a region more PA3720-proximal (endpoints IV in
Fig. 4) failed to bind NalC (Fig. 3D) and little if any binding was
observed to a fragment encompassing the repeat region (endpoints
III) in which the repeat sequence was mutated, and then only at the
highest concentration of NalC (Fig. 3E). This confirmed the repeat
region as the NalC-binding site. Interestingly, a 21-bp fragment
carrying only the IR failed to bind NalC (data not shown) indicating
that the proper disposition of the repeat region for NalC binding
required flanking sequence. The IR-containing region to which
NalC bound contains the putative promoter regions for nalC and
PA3720-armR [predicted using neural network promoter prediction
(http://www.fruitfly.org/seq_tools/promoter.html)] (Fig. 4) as
would be expected. Using 59-RACE the PA3720-armR transcription
start site was mapped to an adjacent CT pair of bases (exact base
could not be determined unequivocally owing to limitations of the
RACE),which occurred downstreamof theputative PA3720-armR -
10 region and immediately downstream of the predicted (using
neural network) start site (Fig. 4). This is consistent with NalC
regulating expression of the PA3720-armR operon.
Figure 1. PCP induction of PA3720-armR. qRT-PCR results showing
impact of PCP and/or a nalC mutation on PA3720 expression (as a
measure of PA3720-armR expression). Expression of PA3720 is reported
relative to the rpsL internal control for wild type P. aeruginosa K767 and
its nalC derivative, K1454 exposed or not to PCP (0.75 mM; 1.5 hr).
Results shown are the mean +/2 standard error of one cDNA sample for
each, processed in triplicate, and are representative of 2 independent
experiments.
doi:10.1371/journal.pone.0032684.g001
Figure 2. PCP modulation of NalC repressor binding to the
PA3720-armR upstream region. A) Mobility shift assay in which
50 ng of a 209-bp DNA fragment encompassing the nalC-PA3720
intergenic region was incubated without (lane 1) or with 200 (lane 2),
300 (lane 3), 400 (lane 4), 500 (lane 5), 800 (lane 6), 1000 (lane 7), 2000
(lane 8) or 3000 (lane 9) ng of purified NalC-His. B) Mobility shift assay in
which purified NalC-His (800 ng) was incubated with 50 ng of a 209-bp
DNA fragment encompassing the nalC-PA3720 intergenic region and
increasing amounts of PCP as indicated. Lane 1, DNA only control.
doi:10.1371/journal.pone.0032684.g002
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dependent but PA3720-ArmR-independent
In addition to its induction of PA320-armR, PCP was previously
shown to induce the MexR-regulated mexAB-oprM multidrug efflux
operon [45], results that have been confirmed here (modest ca. 3-
fold induction; Fig. 5). Mutations in nalC and mexR yielded
elevated expression of mexAB-oprM (nalC, 3-fold; mexR, 5-fold;
Fig. 5), as seen previously [45], and this was no longer responsive
to PCP (Fig. 5). Thus, PCP operates though these regulators in
promoting mexAB-oprM expression. Given that NalC controls
expression of the ArmR anti-repressor that modulates MexR
repression of mexAB-oprM, the obvious interpretation of these
results is that PCP as a NalC effector affords PA3720-armR
expression, with ArmR modulating MexR activity to effect mexAB-
oprM expression. To assess this, PCP induction of the efflux operon
was examined in armR mutant strain K3145. As seen in Fig. 6,
mexAB-oprM was still induced in response to PCP treatment, albeit
to a lesser extent, indicating that PCP induction of this efflux
operon can occur independently of its promotion of ArmR
expression. PA3720 encodes a protein of unknown function that,
like armR, is NalC regulated [37] and PCP inducible [45] (Fig. 1)
and which might, therefore, play a role in PCP induction of
mexAB-oprM. Thus, PCP induction of mexAB-oprM was assessed in a
mutant, K3146, lacking PA3720. Again, however, PCP induction
of mexAB-oprM was retained in the mutant (Fig. 6). Similarly, PCP
induction of mexAB-oprM was seen in a mutant strain, K3130,
lacking both PA3720 and armR (Fig. 6), ruling out both genes
independently mediating PCP induction of the efflux operon.
Similarly, while loss of armR compromised the mexAB-oprM
overexpression seen in a nalC mutant (Fig. 5) in agreement with
previous results [37], PCP induction of mexAB-oprM was retained
in the nalC DarmR mutant K2276 (Fig. 5) again indicating that
PCP induction of the efflux operon can occur independently of
ArmR. Interestingly, however, and in contrast to what was
observed when armR was eliminated in wild type strain K767,
where there was little or no impact on basal levels of mexAB-oprM
expression (in the absence of PCP) (Fig. 6), loss of armR in a nalC
background reduced expression of mexAB-oprM to below the basal
levels seen in K767 (Fig. 5).
PCP is not a MexR effector
The observation that PCP induction of mexAB-oprM is
dependent on MexR but independent of PA3720-armR suggested
that PCP may be capable of directly modulating MexR activity to
effect efflux gene expression. To assess this, the impact of PCP on
MexR binding to a DNA fragment containing the mexAB-oprM
promoter region was examined using EMSA. As seen in Fig. 7
MexR binding was observed, revealing a complex pattern of DNA
Figure 3. Identifying the NalC binding site upstream of
PA3720-armR. A–B) Mobility shift assay in which 50 ng of A) the
107-bp PA3720-distal DNA fragment (sequence delineated by end-
points I in Fig. 4A) or B) the 102-bp PA3720-proximal DNA fragment
(sequence delineated by endpoints II in Fig. 4A) were incubated
without NalC (lane 1) or with 300 (lane 2), 500 (lane 3), 800 (lane 4) or
1000 (lane 5) ng of purified NalC-His. C–E) Mobility shift assay in which 0
(lane 1), 300 (lane 2), 500 (lane 3), 800 (lane 4) and 1000 (lanes 5) and
2000 (lanes 6) ng of purified NalC-his was incubated with 40 ng of C)
the annealed oligonucleotide NalC-1 and its reverse complement
(corresponds to sequence delineated by endpoints III in Fig. 4A), D) the
annealed oligonucleotide NalC-2 and its reverse complement (corre-
sponds to sequence delineated by endpoints IV in Fig. 4A), and E)
annealed oligonucleotide NalC-3 and its reverse complement, in which
the AGAACTGT sequence of NalC-1 corresponding to the first half of the
inverted repeat highlighted in Fig. 4(A) (shaded sequence overlapping
the putative 210 regions for nalC and PA3720-armR) is changed to
TCTTGACA.
doi:10.1371/journal.pone.0032684.g003
Pentachlorophenol Induction of mexAB-oprM
PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e32684binding suggestive of variable occupancy of multiple MexR
binding sites and/or cooperative binding of MexR to its target
DNA. Inn any case, PCP had no impact on MexR binding at
concentrations up to 100 mM, and while there were qualitative
differences in the pattern of shifted DNA at the highest
concentrations (500 and 750 mM) virtually all of the mexAB-oprM
promoter-containing DNA remained bound to MexR at these
concentrations of PCP. Thus, in contrast to NalC, PCP is not an
effector for MexR.
Discussion
ArmR is an anti-repressor that modulates MexR repressor
activity in nalC mutants that hyperexpress the PA3720-armR
operon, accounting for the elevated expression of the mexAB-oprM
multidrug efflux operon in such mutants [37]. In light of the
impact of PCP on NalC repression of the PA3720-armR operon
and the NalC dependence of PCP induction of mexAB-oprM it
seemed reasonable to suppose that PCP induction of the efflux
operon followed from elevated armR expression and subsequent
ArmR-dependent modulation of MexR repression of mexAB-oprM.
Indeed, this was the conclusion of a recent study, published while
this work was in progress, demonstrating that PCP induction of
PA3720-armR expression results from PCP directly modulating
NalC’s repression of this operon [46]. Still, the requirement for
ArmR in PCP-inducible mexAB-oprM expression was not assessed
in that study and results presented here clearly demonstrate that
PCP induction of the efflux operon occurs in the absence of the
anti-repressor. While there seemed to be some reduction in the
Figure 4. Mapping the PA3720-armR transcriptional start site. The nalC/PA3720-armR intergenic region highlighting the RACE-determined
transcription start site for PA3720-armR (bolded and italicized), the predicted transcriptional initiation site (marked with an asterisk; assessed using
neural network promoter prediction software provided by M. G. Reese at http://www.fruitfly.org/seq_tools/promoter.html), the nalC and PA3720 start
codons (arrows), and putative 210/235 sites for nalC (overlined) and PA3720-armR (underlined) promoters. The end-points of PCR-generated
PA3720-distal (I) and -proximal (II) fragments and oligonucleotides (III and IV) used in EMSAs with purified NalC (see Fig. 2B) are identified by
arrowheads above the sequence. The shaded sequence corresponds to an inverted repeat and possible NalC-binding site.
doi:10.1371/journal.pone.0032684.g004
Figure 5. NalC and MexR dependence of PCP induction of
mexAB-oprM. Expression of mexA (as a measure of mexAB-oprM) was
assessed in P. aeruginosa strains K767 (wild type; WT), K1454 (nalC),
K2276 (nalC DarmR) and K2568 (DmexR) exposed or not to PCP
(0.75 mM; 1.5 hr) using qRT-PCR. Expression was normalized to rpsL
controls and is reported relative (fold change) to untreated P.
aeruginosa K767. Results shown are the mean +/2 standard error of
one cDNA sample for each, processed in triplicate, and are represen-
tative of 2 independent experiments.
doi:10.1371/journal.pone.0032684.g005
Figure 6. ArmR-/PA3720-independence of PCP induction of
mexAB-oprM. Expression of mexA (as a measure of mexAB-oprM) was
assessed in P. aeruginosa strains K767 (wild type; WT), K3145 (DarmR),
K3146 (DPA3720) and K3130 (DPA3720-armR) exposed or not to PCP
(0.75 mM; 1.5 hr) using qRT-PCR. Expression was normalized to rpsL
controls and is reported relative (fold change) to untreated P.
aeruginosa K767. Results shown are the mean +/2 standard error of
one cDNA sample for each, processed in triplicate, and are represen-
tative of 2 independent experiments.
doi:10.1371/journal.pone.0032684.g006
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absence of armR, all mutants lacking armR (i.e., K767DarmR,
nalCDarmR, K767DPA3720DarmR) showed fold increases in
expression of the efflux genes in the presence of PCP (2- to 3-
fold increase) that were similar to wild type strain K767 (ca. 3-
fold).
While it is unlikely that elevated armR expression in PCP-treated
P. aeruginosa would not contribute to mexAB-oprM expression as a
result of ArmR modulation of MexR repressor activity, these
results do indicate that there are other mechanisms by which PCP
can promote mexAB-oprM expression, probably in parallel with the
ArmR-dependent mechanism. Such a mechanism appears not to
involve PA3720, whose function still remains to be elucidated, but
does require MexR, which may respond to PCP. Given the
observation that PCP does not impact MexR binding to the
mexAB-oprM promoter containing DNA in vitro, one possibility is
that P. aeruginosa exposure to PCP promotes in vivo production of
MexR effector molecule(s) that facilitate mexAB-oprM derepression.
In this vein, it has been shown that MexR binding to the mexAB-
oprM promoter region and its control of efflux gene expression is
impacted by oxidative stress, MexR being a redox responsive
regulator whose ability to bind and repress mexAB-oprM is
compromised when the protein is oxidized [33,34]. Thus,
exposure to hydroperoxide oxidizes MexR and alleviates promoter
binding in vitro and induces mexAB-oprM expression in vivo [34].
One possibility, then, is that PCP exposure generates some form of
oxidative stress in P. aeruginosa. Intriguingly, PCP has been shown
to dramatically increase O2 flux in P. aeruginosa, generating an
oxidative stress that could impact MexR activity [54]. Puzzlingly,
PCP induction of mexAB-oprM is absent in nalC mutant K1454,
despite the fact that efflux gene expression is less than what is seen
in a mexR null strain (K2568) – while much of MexR is inactive as
a repressor in K1454, being bound by ArmR, clearly some MexR
repression of mexAB-oprM is still occurring and would, presumably,
be susceptible to modulation by PCP (or PCP-generated effectors).
Still, there is some unexplained complexity to mexAB-oprM
expression in a nalC strain given the greater impact of armR loss
on efflux gene expression in a nalC background as compared to an
otherwise wild type background where in absolute terms mexAB-
oprM expression is less (2-fold; Fig. 5) in a nalC DarmR mutant
(K2276) than a DarmR mutant (K3145). Whether this explains the
anomaly, there is likely to be differences in the expression of at
least some genes in K2276 vs. K3145, with PA3720 presumably
up-regulated in the former but not the latter and any other genes
impacted by loss of nalC and/or upregulation of PA3720
differentially expressed in the two strains. How these might
influence mexAB-oprM expression is uncertain.
The modulation of NalC repressor activity by PCP (and other
chlorinated phenols [46]) occurs at high levels (high mM to low
mM) for an effector molecule suggesting that it only mimics an
intended NalC effector and ultimate inducer of mexAB-oprM, likely
a phenolic of some kind. Plants are common sources of phenolic
compounds, many of which have antimicrobial activity [55–58],
and these may be the intended inducers/substrates for MexAB-
OprM. While attempts were made to assess the ability of plant
extracts to ‘interact’ with NalC and to induce mexAB-oprM
expression technical issues (extract insolubility in aqueous
solutions) compromised these efforts.
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